Loading clinical trials...
Loading clinical trials...
Noninvasive Testing Procedures, Role of Biomarkers and Anticancer Treatments in Esophageal and Esophagogastric Cancer Survival and Quality of Life of Patients With Cancer of the Esophageopharyngeal and Oesophageophageophageal Junction
Conditions
Locations
1
Hungary
Semmelweis University
Budapest, Hungary
Start Date
September 10, 2024
Primary Completion Date
September 30, 2029
Completion Date
September 10, 2034
Last Updated
April 24, 2026
NCT06869213
NCT07211009
Lead Sponsor
Semmelweis University
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions